Oops! [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2011-02-07 19:35 (5249 d 00:30 ago) – Posting: # 6573
Views: 26,906

Dear HS,

❝ No requirement for blinding to treatment effect at each stage, since data would routinely be unblinded in pharmacokinetic (PK) BE studies.


That's a pretty good point to raise given my previous post :rotfl:

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,673 registered users;
35 visitors (0 registered, 35 guests [including 8 identified bots]).
Forum time: 21:05 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5